Results 111 to 120 of about 7,827 (211)

Hepatic adverse events associated with ketamine and esketamine: A population-based disproportionality analysis

open access: yes
Background and objective: To determine whether there is disproportionate reporting of hepatobiliary disorders in the United States (US) FDA Adverse Event Reporting System (FAERS) for individuals prescribed ketamine or esketamine.
Le, Gia Han   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy